17-beta-hydroxysteroid dehydrogenase deficiency screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{Abdulkerim}}
{{CMG}}; {{AE}} {{Abdulkerim}}
==Overview==
==Overview==
There is insufficient evidence to recommend routine screening for 17 alpha-hydroxylase deficiency
*There is insufficient evidence to recommend routine screening for 17 alpha-hydroxylase deficiency.
 
==Screening==
==Screening==
*There is insufficient evidence to recommend routine screening for 17 alpha-hydroxylase deficiency.
*There is insufficient evidence to recommend routine screening for 17 alpha-hydroxylase deficiency.

Revision as of 07:16, 7 October 2022

17-beta-hydroxysteroid dehydrogenase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17-beta-hydroxysteroid dehydrogenase deficiency screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17-beta-hydroxysteroid dehydrogenase deficiency screening

CDC on 17-beta-hydroxysteroid dehydrogenase deficiency screening

17-beta-hydroxysteroid dehydrogenase deficiency screening in the news

Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency screening

Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency

Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]

Overview

  • There is insufficient evidence to recommend routine screening for 17 alpha-hydroxylase deficiency.

Screening

  • There is insufficient evidence to recommend routine screening for 17 alpha-hydroxylase deficiency.

References

Template:WH Template:WS